Could a vaccine be approved in October?

Stat explains the process the Food and Drug Administration (FDA) would follow to approve a COVID-19 vaccine before clinical trials have ended. The Washington Post reports that some people are concerned about the FDA using emergency authorization to do so, while others argue such action could save lives if properly executed. And NPR talks with a White House vaccine adviser who is skeptical of the timeline. Reuters describes the debate around qualified immunity — a legal doctrine that shields police from lawsuits while they’re on the job. Derek Thompson writes for the Atlantic about how, throughout history, visionary responses to catastrophes have changed urban life for the better. And he argues that the coronavirus pandemic might present another such opportunity for us to improve our cities. The Wall Street Journal collects advice from executives and career experts about how to look for a job during the pandemic.